Collegium Pharmaceutical Inc. (COLL)
NASDAQ · Healthcare
Collegium Pharmaceutical Inc. annual/quarterly long term debt history from 2016 to 2019. Long term debt refers to financial obligations that are due more than one year in the future.
- Collegium Pharmaceutical Inc. long term debt for the quarter ending December 31, 2019 were 11.5M, a 0.00% increase year-over-year.
- Collegium Pharmaceutical Inc. long term debt for 2019 were 11.5M, a 0.00% increase from 2018.
- Collegium Pharmaceutical Inc. long term debt for 2018 were 11.5M, a 177.38% increase from 2016.
- Collegium Pharmaceutical Inc. long term debt for 2016 were 4.1M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Collegium Pharmaceutical Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2019 | $12 |
| 2018 | $12 |
| 2016 | $4 |
| Collegium Pharmaceutical Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2019-12-31 | $12 |
| 2018-12-31 | $12 |
| 2016-12-31 | $4 |
Collegium Pharmaceutical Inc. Long Term Debt — FAQ
Collegium Pharmaceutical Inc. (COLL) long term debt over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see COLL's long term debt history?
The chart and table above show Collegium Pharmaceutical Inc.'s long term debt by year and by quarter, including the growth rate.